drugset / Trial / NCT00444548

Evaluation of A Novel Methodology in the Assessment of Urethral Function Using [S,S]-Reboxetine in Healthy Volunteers

NCT00444548

Completed 12 enrolled Pfizer
RandomizedCrossoverDouble-blindTreatment

Summary

\[S,S\]-Reboxetine will be used to evaluate pharmacodynamic changes in urethral function in healthy volunteers using a novel methodology

Timeline

Start
2007-05
Primary completion
Completion
2007-07

Drugs

EvaluationDrugModalityDoseRoute
Subject [S,S]-Reboxetine Unknown

Indications

No indication recorded.